Atlas Trials

The Efficacy of Cobitolimod in Patients With Moderate to Severe Active Ulcerative Colitis

Clinical trial NCT03178669 · COMPLETED

Trial details

NCT number
NCT03178669
Sponsor
InDex Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Ulcerative Colitis
Start date
2017-06-21
Primary completion
2019-08-30
Enrollment
213

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.